Company Search:
Advanced Search
Sponsored Links
YBCC Inc Company Snapshot
YBCC Inc operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares YBCC Inc with three other pharmaceutical manufacturers in North America: Dare Bioscience Inc (2016 sales of $766,000.00 ), Stellar Biotechnologies, Inc. of Canada (1.68 million Canadian Dollars [US$1.35 million] ), and Aurora Cannabis Inc which is also based in Canada (1.44 million Canadian Dollars [US$1.16 million] ).

Sales Analysis. Sales fell dramatically in 2016: YBCC Inc reported sales of $1.13 million for the year ending December of 2016. This represents a sharp decrease of 97.1% versus 2015, when the company's sales were $38.50 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for YBCC Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/18/2018): .29
(Figures in U.S. Dollars)
1 Week 45.0%   13 Weeks 152.1%  
4 Weeks 141.7%   52 Weeks -60.8%  
YBCC Inc Key Data:
  Ticker: YBAO Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 1,130,743
(Year Ending Jan 2017).
Employees: 5
  Currency: U.S. Dollars Market Cap: 2,869,322
  Fiscal Yr Ends: December Shares Outstanding: 9,894,214
  Share Type: Common Closely Held Shares: 4,370,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.